Biovance Capital
Founded 2024
About Biovance Capital
Biovance Capital is a new € 51M fund to invest in early-stage biotech companies across Europe developing innovative therapeutics in all disease areas and drug modalities (small and large molecules, vaccines, cell, and gene therapies).
Company Facts
- Founded: 2024
- Operating status: Operating
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $50K – $100K
- Website: biovancecapital.com
Social Profiles
Canonical: https://fsome.com/organization/biovance-capital-8242059 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.